Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raffaele A Calogero

Showing results (91-100 of 97) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 97 results.
Cancer Cell|August 5, 2014
The Hippo transducer YAP1 transforms activated satellite cells and is a potent effector of embryonal rhabdomyosarcoma formationAnnie M Tremblay, Edoardo Missiaglia, Giorgio G Galli, et al.
International Journal of Molecular Sciences|April 3, 2021
Different miRNA Profiles in Plasma Derived Small and Large Extracellular Vesicles from Patients with Neurodegenerative DiseasesDaisy Sproviero, Stella Gagliardi, Susanna Zucca, et al.
Nature|February 7, 2020
Live-animal imaging of native haematopoietic stem and progenitor cellsConstantina Christodoulou, Joel A Spencer, Shu-Chi A Yeh, et al.
Plos Genetics|September 5, 2014
Histone methyltransferase MMSET/NSD2 alters EZH2 binding and reprograms the myeloma epigenome through global and focal changes in H3K36 and H3K27 methylationRelja Popovic, Eva Martinez-Garcia, Eugenia G Giannopoulou, et al.
Scientific Reports|January 16, 2021
Early stability and late random tumor progression of a HER2-positive primary breast cancer patient-derived xenograftLorena Landuzzi, Arianna Palladini, Claudio Ceccarelli, et al.
Cells|February 21, 2020
<i>PIK3R1</i><sup>W624R</sup> Is an Actionable Mutation in High Grade Serous Ovarian CarcinomaConcetta D'Ambrosio, Jessica Erriquez, Maddalena Arigoni, et al.
Blood Advances|October 9, 2021
Frequent mutations of FBXO11 highlight BCL6 as a therapeutic target in Burkitt lymphomaChiara Pighi, Taek-Chin Cheong, Mara Compagno, et al.
Pageof 10

Showing results (91-100 of 97) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 97 results.
Cancer Cell|August 5, 2014
The Hippo transducer YAP1 transforms activated satellite cells and is a potent effector of embryonal rhabdomyosarcoma formationAnnie M Tremblay, Edoardo Missiaglia, Giorgio G Galli, et al.
International Journal of Molecular Sciences|April 3, 2021
Different miRNA Profiles in Plasma Derived Small and Large Extracellular Vesicles from Patients with Neurodegenerative DiseasesDaisy Sproviero, Stella Gagliardi, Susanna Zucca, et al.
Nature|February 7, 2020
Live-animal imaging of native haematopoietic stem and progenitor cellsConstantina Christodoulou, Joel A Spencer, Shu-Chi A Yeh, et al.
Plos Genetics|September 5, 2014
Histone methyltransferase MMSET/NSD2 alters EZH2 binding and reprograms the myeloma epigenome through global and focal changes in H3K36 and H3K27 methylationRelja Popovic, Eva Martinez-Garcia, Eugenia G Giannopoulou, et al.
Scientific Reports|January 16, 2021
Early stability and late random tumor progression of a HER2-positive primary breast cancer patient-derived xenograftLorena Landuzzi, Arianna Palladini, Claudio Ceccarelli, et al.
Cells|February 21, 2020
<i>PIK3R1</i><sup>W624R</sup> Is an Actionable Mutation in High Grade Serous Ovarian CarcinomaConcetta D'Ambrosio, Jessica Erriquez, Maddalena Arigoni, et al.
Blood Advances|October 9, 2021
Frequent mutations of FBXO11 highlight BCL6 as a therapeutic target in Burkitt lymphomaChiara Pighi, Taek-Chin Cheong, Mara Compagno, et al.
Pageof 10